(Q44943572)

English

Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

based on heuristic

inferred from title

Olivier Hermine

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ibrahim Yakoub-Agha

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Charles Craddock

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jakob R. Passweg

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

I Avivi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

C Canals

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

J-P Vernant

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

G Wulf

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

A Nagler

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

E Petersen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

A Schattenberg

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

D Niederwieser

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

K Thomson

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

D Blaise

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

M Pfreundschuh

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

N Russell

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

P Dreger

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

A Sureda

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

EBMT Lymphoma Working Party

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

0 references

publication date

10 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

671-678

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Relapsed/refractory diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellu

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Defining the intensity of conditioning regimens: working definitions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Clinical Outcome following Autologous and Allogeneic Blood and Marrow Transplantation for Relapsed Diffuse Large-Cell Non-Hodgkin’s Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.4

21 January 2018

Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Reg

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2014.4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510071%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44943572&oldid=2207002525"